Combination therapies: a journey into personalized vaccine immunotherapeutics for early-stage cancers

Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks with Stephen Johnston, CEO, Calviri, about the shift in the I-O space to preventative treatment in combination for early­-stage cancers.

Please enter your email to access content Read now